Our study replicates and further corroborates these previous findings by including healthy individuals, and, furthermore, assessed the levels of ABCC2 and ABCG2 in the normal-mild dysplasia-severe dysplasia-carcinoma sequence. This evidence concerns the gene ABCC2 and dysplasia.